Prof. Dr. Freimut Schliess
Mentor & Consultant
Your clinical investigations are key to evidence-based market success. But: for sustainable competitiveness and growth your evidence strategy must be broader.
I provide you with a more holistic approach: beyond facilitating the design and implementation of your purposive clinical trials I help you early manage diverse views of stakeholders, benefit from pan-European research & innovation, and scientifically communicate your value proposition and evidence. I bring to the table the many years of expertise and experience I have gained in industry, health insurance and academic science, as well as my passion for impactful innovations and supporting the entrepreneurial teams behind.
​
Together we make your market success a reality - through an evidence strategy precisely tailored to you, your target market and your value proposition.
Background
-
30+ years in the life sciences sector: industry, statutory health insurance and academia
-
Launch of digital health innovations (hybrid care, rehabilitation, public funds) for a consortium of 30+ statutory health insurance companies.
-
14+ years in clinical contract research at a full-service CRO: implementation of translational research, proof-of-concept studies and pivotal clinical trials in drug and medical device development. Focus on diabetes, obesity, MAFLD/MASH and cardiometabolic disease.
-
Co-founder of the pan-European EIT Health public-private partnership having cumulated three-digit million € in funding to date.
-
Initiator and leader of European business & innovation consortia in digital health with multi-million € budgets of EU funding and partners own resources.
-
Member/Chair of international and national Supervisory Boards.
-
Member of the EIT Health Mentoring & Coaching Network.
-
Appointed Adjunct Professor, Habilitation and Venia Legendi for the subject Molecular Medicine. Research priorities: metabolism, insulin resistance, liver disease, mental health.
-
Scientific secretary of a Collaborative Research Center funded by the German Research Foundation (DFG).
-
10 years of continuous DFG funding as a scientific project leader in Experimental Diabetology and Hepatology.
-
Author of 90+ peer-reviewed publications.
-
Evaluator of innovation, business and research proposals. Juror in start-up competitions. Reviewer for peer-reviewed scientific journals and funding agencies.
-
Speaker, trainer and facilitator at symposia, roundtables, summer schools, think tanks, co-creation events and consortia meetings.
-
PhD in Molecular Neurology (multiple sclerosis reseach), Diploma in Chemistry.
-
What else? Member of the volunteer team of a retirement home, playing music (cello and piano), doing sports (endurance & strength training).
Customer Feedback
Pauline Nöldemann and Yannick Wiesner
Co-CEOs and Founders of BesserEsser (Germany)
We feel honored to work with Prof. Dr. Freimut Schliess on our journey towards bringing our artificial intelligence-powered detection of food intolerances to the patients. Freimut contributes a deep understanding of the German statutory health insurance (GKV) system which helped us navigating the complex processes, patient journeys, and reimbursement pathways. We worked together to sharpen our value propositon and the positioning of „BesserEsser" in the nutritional health market which brought our pitch to health insurers and investors to the point. Freimut's support has been invaluable in ensuring our app meets all regulatory requirements and receives excellent feedback from health insurance companies and users. Through his extensive network, Freimut has connected us with key decision-makers and existing solutions in the digital health ecosystem and opened doors to strategic partnerships and collaborations. With his enthusiasm and collaborative spirit Freimut has created a dynamic atmosphere in which working together is really fun. We are deeply grateful for Freimut's support and look forward to continuing our successful collaboration.
Dorian Koch
Co-Founder of MedKitDoc (Germany), Ex-McK
I experienced Freimut as a very competent person who quickly established effective communication with our team. Consulting topics included generating evidence of our medical device-assisted telemedicine that sets us apart from competitors, developing a use case of telemedical care for nursing home residents, and further enhancing the technological integration of remote diagnostics. Freimut impressed me with his strong vision for the future of telemedicine. At the same time, he was very flexible and responded to our needs with pragmatic suggestions. The outcomes of our working sessions have had a lasting influence on our business development. I warmly recommend Freimut as a Mentor and Consultant to all companies that want to gain a foothold in the reimbursement market.
Julia Kern and Adrian Brodesser
Co-CEOs of SOMAREALITY (Austria)
SOMAREALITY provides a software development kit that enables a real-time continuous quantification of cognitive states outside the laboratory setting. Freimut supported our team with his regulatory expertise in analyzing medical and non-medical use cases with regard to their implications for the (borderline) classification of our algorithm as a medical device and the need for studies according to MDR and IVDR. In addition, Freimut connected us with scientific and clinical key opinion leaders from his network in the areas of neuropsychology, machine learning & data analytics, ambient assisted living and robotics, which enables us to further expand our collaborative research and development. We got to know Freimut as an experienced, knowledgeable and extremely well-connected advisor who was able to adapt very well to our current agenda and give us valuable inspiration for further business development. We can only recommend Freimut as an advisor and are already looking forward to future projects with him.